Legal & General Group PLC Abbott Laboratories Transaction History

Legal & General Group PLC

$420 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Legal & General Group PLC holds 14,205,391 shares of ABT stock, worth $1.45 Billion. This represents 0.38% of its overall portfolio holdings.

Number of Shares

14,205,391

Previous 14,299,250 0.66%

Holding current value

$1.45 Billion

Previous $1.57 Billion 2.58%

% of portfolio

0.38%

Previous 0.41%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $10.3 Million - $11.4 Million	-93,859 Reduced 0.66%	14,205,391 $1.61 Billion
Q4 2023 Feb 15, 2024	BUY	$90.19 - $110.4 $169 Million - $207 Million	1,873,411 Added 15.08%	14,299,250 $1.57 Billion
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $38.9 Million - $46.7 Million	-407,288 Reduced 3.17%	12,425,839 $1.2 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $51.2 Million - $57.1 Million	508,439 Added 4.13%	12,833,127 $1.4 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $4.35 Million - $5.12 Million	44,918 Added 0.37%	12,324,688 $1.25 Billion

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $58.2 Million - $68.3 Million	-612,544 Reduced 4.75%	12,279,770 $1.35 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $34.8 Million - $40.3 Million	-360,116 Reduced 2.72%	12,892,314 $1.25 Billion
Q2 2022 Aug 22, 2022	BUY	$102.07 - $123.37 $57.7 Million - $69.8 Million	565,475 Added 4.46%	13,252,430 $1.44 Billion
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $86.9 Million - $106 Million	761,956 Added 6.39%	12,686,955 $1.5 Billion
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $45.1 Million - $55.2 Million	-389,988 Reduced 3.17%	11,924,999 $1.68 Billion
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $51.8 Million - $57.3 Million	443,776 Added 3.74%	12,314,987 $1.45 Billion
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $66.8 Million - $78.6 Million	631,380 Added 5.62%	11,871,211 $1.38 Billion
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $12.5 Million - $14.7 Million	-114,771 Reduced 1.01%	11,239,831 $1.35 Billion
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.13 Million - $1.23 Million	-10,746 Reduced 0.09%	11,354,602 $1.24 Billion
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $12.4 Million - $15.1 Million	135,441 Added 1.21%	11,365,348 $1.24 Billion
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $10.1 Million - $12.9 Million	131,920 Added 1.19%	11,229,907 $1.03 Billion
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $24.1 Million - $35.3 Million	384,420 Added 3.59%	11,097,987 $876 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $7.74 Million - $8.61 Million	98,562 Added 0.93%	10,713,567 $931 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $14.3 Million - $15.5 Million	174,158 Added 1.67%	10,615,005 $888 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $43,436 - $50,660	-596 Reduced 0.01%	10,440,847 $878 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $139 Million - $168 Million	2,098,441 Added 25.15%	10,441,443 $835 Million
Q4 2018 Feb 15, 2019	BUY	$65.56 - $74.27 $44.1 Million - $49.9 Million	672,358 Added 8.77%	8,343,002 $603 Million
Q3 2018 Nov 20, 2018	BUY	$60.81 - $73.36 $7.38 Million - $8.91 Million	121,421 Added 1.61%	7,670,644 $563 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $20.2 Million - $22.2 Million	-350,061 Reduced 4.43%	7,549,223 $460 Million
Q1 2018 May 17, 2018	SELL	$56.27 - $63.62 $37.8 Million - $42.8 Million	-672,382 Reduced 7.84%	7,899,284 $473 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $460 Million - $493 Million	8,571,666	8,571,666 $489 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Abbott Laboratories Transaction History